You searched for "respiratory"
Sustainability in ophthalmology and healthcare: An overview
Finally, even staunch sceptics are coming around to recognising that climate change is real and that we should do something about it. But how proximal the threat is and at what pace change has to happen is not universally agreed...The expanding role of the optometrist
Eyecare in the UK has seen significant changes in recent years, with new models of care, technological advancements and an increased emphasis on primary eyecare in some UK nations. Crucially, an ageing population demographic is set to escalate further both...Building data infrastructure for eye research in the NHS: Real-world lessons from the Liverpool Eye Data Platform
The Liverpool Eye Data Platform demonstrates how governance-compliant infrastructure can bring together routinely-collected, siloed NHS eye data. Routine care delivered across the NHS generates vast amounts of clinical data within a healthcare system that is uniquely characterised by comprehensive population...NYU Langone Health performs world’s first whole-eye & partial-face transplant
Landmark whole-eye transplant is a major paradigm shift for potential vision therapies.Illuminating task lighting
Good lighting is always important but especially for patients who are visually impaired. Janet Pooley provides an overview. We tend to discuss lighting with patients when their vision is reduced, and where we are considering higher reading adds or low...OPO celebration event marks 100-years of groundbreaking research in vision science and optometry
The College of Optometrists hosted academics from across the UK and internationally at a special symposium to mark 100-years of its research journal Ophthalmic and Physiological Optics (OPO) at Glasgow Caledonian University. OPO Centenary: Celebrating Research Excellence saw academics and...
Intravitreal dexamethasone implant for recurrent CMO secondary to IGS
In this prospective study the authors present the data obtained on the efficacy and safety of the dexamethasone implant (0.7 mg) in the treatment of recurrent cystoid macular oedema (PCME) due to Irvine–Gass syndrome in patients with uncomplicated pseudophakia (off-label...
